143 related articles for article (PubMed ID: 28178129)
1. Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.
Ağababaoğlu İ; Önen A; Demir AB; Aktaş S; Altun Z; Ersöz H; Şanl A; Özdemir N; Akkoçlu A
Medicine (Baltimore); 2017 Feb; 96(6):e5903. PubMed ID: 28178129
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of annexin II expression in non-small cell lung cancer.
Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients.
Tang Y; Yang Y; Luo J; Liu S; Zhan Y; Zang H; Zheng H; Zhang Y; Feng J; Fan S; Wen Q
Cancer Biomark; 2021; 30(1):85-94. PubMed ID: 32986659
[TBL] [Abstract][Full Text] [Related]
4. New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma.
Wadowska K; Błasiak P; Rzechonek A; Bil-Lula I; Śliwińska-Mossoń M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439874
[TBL] [Abstract][Full Text] [Related]
5. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocarcinoma.
Xu X; Wang W; Shao W; Yin W; Chen H; Qiu Y; Mo M; Zhao J; Deng Q; He J
J Surg Oncol; 2011 Nov; 104(6):598-603. PubMed ID: 21671464
[TBL] [Abstract][Full Text] [Related]
7. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
[TBL] [Abstract][Full Text] [Related]
8. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
[TBL] [Abstract][Full Text] [Related]
9. Proteomic biomarkers for lung cancer progression.
Ren Y; Zhao S; Jiang D; Feng X; Zhang Y; Wei Z; Wang Z; Zhang W; Zhou QF; Li Y; Hou H; Xu Y; Zhou F
Biomark Med; 2018 Mar; 12(3):205-215. PubMed ID: 29424557
[TBL] [Abstract][Full Text] [Related]
10. [Comparative proteome analysis of human lung squamous cell carcinoma].
Tang CE; Li C; Xiao ZQ; Zhang XP; Chen ZC; Yi H; Li JL; Duan CJ; Liang SP
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):274-9. PubMed ID: 16875628
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma.
Zhou X; Xue L; Hao L; Liu S; Zhou F; Xiong H; Qi X; Lin D; Shao S
Biomed Pharmacother; 2013 Sep; 67(7):621-7. PubMed ID: 23916545
[TBL] [Abstract][Full Text] [Related]
13. Proteomic patterns of tumour subsets in non-small-cell lung cancer.
Yanagisawa K; Shyr Y; Xu BJ; Massion PP; Larsen PH; White BC; Roberts JR; Edgerton M; Gonzalez A; Nadaf S; Moore JH; Caprioli RM; Carbone DP
Lancet; 2003 Aug; 362(9382):433-9. PubMed ID: 12927430
[TBL] [Abstract][Full Text] [Related]
14. Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer.
Rappa F; Pitruzzella A; Marino Gammazza A; Barone R; Mocciaro E; Tomasello G; Carini F; Farina F; Zummo G; Conway de Macario E; Macario AJ; Cappello F
Cell Stress Chaperones; 2016 Sep; 21(5):927-33. PubMed ID: 27491302
[TBL] [Abstract][Full Text] [Related]
15. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis.
Tian T; Hao J; Xu A; Hao J; Luo C; Liu C; Huang L; Xiao X; He D
Cancer Sci; 2007 Aug; 98(8):1265-74. PubMed ID: 17537172
[TBL] [Abstract][Full Text] [Related]
16. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry.
Xiao H; Zhang L; Zhou H; Lee JM; Garon EB; Wong DT
Mol Cell Proteomics; 2012 Feb; 11(2):M111.012112. PubMed ID: 22096114
[TBL] [Abstract][Full Text] [Related]
18. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
[TBL] [Abstract][Full Text] [Related]
19. Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer.
Lee HS; Park JW; Chertov O; Colantonio S; Simpson JT; Fivash MJ; Yoo CW; Lee GK; Zo JI; Kim HT; Kim HK
Pathol Int; 2012 Jan; 62(1):28-35. PubMed ID: 22192801
[TBL] [Abstract][Full Text] [Related]
20. Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer.
Oshita F; Morita A; Ito H; Kameda Y; Tsuchiya E; Asai S; Miyagi Y
Oncol Rep; 2010 Sep; 24(3):637-45. PubMed ID: 20664968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
